STOCK TITAN
  1. Home
  2. Sec-filings
  3. AIM
  4. [EFFECT] AIM ImmunoTech Inc. SEC Filing

[EFFECT] AIM ImmunoTech Inc. SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
EFFECT
Rhea-AI Filing Summary
Riscrivi il testo seguente:
Reescribe el siguiente texto:
다음 텍스트를 다시 작성하세요:
Réécrivez le texte suivant :
Schreibe den folgenden Text um:
Positive
  • None.
Negative
  • None.
Riscrivi il testo seguente:
Reescribe el siguiente texto:
다음 텍스트를 다시 작성하세요:
Réécrivez le texte suivant :
Schreibe den folgenden Text um:
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date: July 3, 2025 4:00 P.M.
Form: S-3
CIK: 0000946644
Company Name: AIM ImmunoTech Inc.
File Number: 333-286319

Source: View Original Filing on SEC EDGAR

Stock AIM logo
Aim Immunotech

NYSE:AIM

AIM Rankings

#9817 Ranked by Market Cap
N/A Ranked by Dividends

AIM Latest News

Jul 2, 2025
AIM ImmunoTech Announces Recent Presentation on the Potential of Private-Public Partnerships for the Development of Oncology Therapies
Jun 20, 2025
AIM ImmunoTech Announces NYSE American Notice of Noncompliance With Minimum Stockholders’ Equity Requirements
Jun 17, 2025
AIM ImmunoTech Resumes Trading on NYSE American
Jun 12, 2025
AIM ImmunoTech Granted U.S. Patent Covering Methods of Manufacturing Therapeutic dsRNA, Including Ampligen®
Jun 12, 2025
AIM ImmunoTech Announces NYSE American Removal of Trading Suspension

AIM Latest SEC Filings

Jun 27, 2025
[S-3/A] AIM ImmunoTech Inc. Amended Shelf Registration Statement
Jun 20, 2025
[8-K] AIM ImmunoTech Inc. Reports Material Event

AIM Stock Data

6.76M
671.74k
10.11%
12.54%
4.78%
Biotechnology
Biological Products, (no Disgnostic Substances)
Link
United States
OCALA